Associate Director, Risk​/Patient Preference

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and Med Tech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more at

Data Analytics & Computational Sciences

Epidemiology

Scientific/Technology

Cambridge, Massachusetts, United States of America
Horsham, Pennsylvania, United States of America
Raritan, New Jersey, United States of America
Titusville, New Jersey, United States of America

We are searching for the best talent for our Associate Director, Benefit Risk/Patient Preference position, to be based in Titusville, NJ;
Raritan, NJ;
Horsham, PA or Cambridge, MA. Remote work options may be considered on a case-by-case basis and if approved by the Company.

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.

Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.

Learn more at

The Associate Director, Benefit-Risk / Patient Preference will be part of the Benefit-Risk Team within Global Epidemiology in Innovative Medicine and serve as an expert and consultant for benefit-risk methodology, patient preference studies and patient-focused drug development, collaborating with and supporting Johnson & Johnson colleagues in cross-functional teams across The Office of the Chief Medical Officer, R&D and the Global Commercial Strategy Organization.

• Leading structured benefit-risk assessments and patient preference studies including:
• Guiding clinical teams in benefit-risk assessment of products in development
• Leading preference studies to support products in development, including designing preference studies for internal advisory boards
• Applying structured patient preference, benefit-risk and decision analysis methods throughout the development lifecycle
• Contributing as an author to internal and regulatory documents (e.g., statistical analysis plans, submission documents)
• Serving as an internal subject matter expert on these topics

Keeping up to date with guidance and policy produced by regulatory agencies and other critical organizations regarding methodologies for benefit-risk assessment, patient preference studies and patient-focused drug development. Standard tools expected to be used in this role include:

• Benefit-risk frameworks
• Value trees
• Statistical analysis plans
• Effects tables
• Qualitative and quantitative preference methods

Lead benefit-risk and preference studies for development strategy, dose selection, clinical trials, regulatory documents, health authority advisory committee meetings, safety decisions, treatment access and providing guidance on use of real-world evidence in benefit-risk assessment.

Assist with internal benefit-risk process development and training, developing novel means to communicate and display preference and benefit-risk information, participating in external benefit-risk methodology and policy activities, authoring publications on their research and presenting at internal/external meetings.

Work closely with members of the Global Epidemiology, Clinical and Global Medical Safety departments and collaborate with colleagues in cross-functional teams in performing these responsibilities.

• Master’s degree in Decision Sciences, Health Economics, Epidemiology, Biostatistics, Public Health, or a related scientific discipline required;
  PhD or MD strongly preferred. MD applicants must also have a degree or certificate in one of these disciplines.

• A minimum of 5 years (3 year for PhD or MD)…